These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 27481036)

  • 61. Fecal Microbiome Among Nursing Home Residents with Advanced Dementia and Clostridium difficile.
    Araos R; Andreatos N; Ugalde J; Mitchell S; Mylonakis E; D'Agata EMC
    Dig Dis Sci; 2018 Jun; 63(6):1525-1531. PubMed ID: 29594967
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Update of treatment algorithms for Clostridium difficile infection.
    Ooijevaar RE; van Beurden YH; Terveer EM; Goorhuis A; Bauer MP; Keller JJ; Mulder CJJ; Kuijper EJ
    Clin Microbiol Infect; 2018 May; 24(5):452-462. PubMed ID: 29309934
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Microbiome data distinguish patients with Clostridium difficile infection and non-C. difficile-associated diarrhea from healthy controls.
    Schubert AM; Rogers MA; Ring C; Mogle J; Petrosino JP; Young VB; Aronoff DM; Schloss PD
    mBio; 2014 May; 5(3):e01021-14. PubMed ID: 24803517
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis.
    Trifan A; Stanciu C; Girleanu I; Stoica OC; Singeap AM; Maxim R; Chiriac SA; Ciobica A; Boiculese L
    World J Gastroenterol; 2017 Sep; 23(35):6500-6515. PubMed ID: 29085200
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Host factors are more important in predicting recurrent Clostridium difficile infection than ribotype and use of antibiotics.
    van Beurden YH; Nezami S; Mulder CJJ; Vandenbroucke-Grauls CMJE
    Clin Microbiol Infect; 2018 Jan; 24(1):85.e1-85.e4. PubMed ID: 28782647
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Control of
    Collins J; Auchtung JM
    Microbiol Spectr; 2017 Sep; 5(5):. PubMed ID: 28936948
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Identification of key taxa that favor intestinal colonization of Clostridium difficile in an adult Chinese population.
    Gu S; Chen Y; Zhang X; Lu H; Lv T; Shen P; Lv L; Zheng B; Jiang X; Li L
    Microbes Infect; 2016 Jan; 18(1):30-8. PubMed ID: 26383014
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prediction of recurrent clostridium difficile infection at the bedside: the GEIH-CDI score.
    Cobo J; Merino E; Martínez C; Cózar-Llistó A; Shaw E; Marrodán T; Calbo E; Bereciartúa E; Sánchez-Muñoz LA; Salavert M; Pérez-Rodríguez MT; García-Rosado D; Bravo-Ferrer JM; Gálvez-Acebal J; Henríquez-Camacho C; Cuquet J; Pino-Calm B; Torres L; Sánchez-Porto A; Fernández-Félix BM;
    Int J Antimicrob Agents; 2018 Mar; 51(3):393-398. PubMed ID: 28939450
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Predictors of first recurrence of Clostridium difficile infections in children.
    Tschudin-Sutter S; Tamma PD; Milstone AM; Perl TM
    Pediatr Infect Dis J; 2014 Apr; 33(4):414-6. PubMed ID: 24168983
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Factors associated with Clostridium difficile infection: A nested case-control study in a three year prospective cohort.
    Khanafer N; Vanhems P; Barbut F; Luxemburger C; ; Demont C; Hulin M; Dauwalder O; Vandenesch F; ; Argaud L; Badet L; Barth X; Bertrand M; Burillon C; Chapurlat R; Chuzeville M; Comte B; Disant F; Fessy MH; Gouillat C; Juillard L; Lermusiaux P; Monneuse O; Morelon E; Ninet J; Ponchon T; Poulet E; Rimmele T; Tazarourte K
    Anaerobe; 2017 Apr; 44():117-123. PubMed ID: 28279859
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Treatment approaches including fecal microbiota transplantation for recurrent Clostridium difficile infection (RCDI) among infectious disease physicians.
    Bakken JS; Polgreen PM; Beekmann SE; Riedo FX; Streit JA
    Anaerobe; 2013 Dec; 24():20-4. PubMed ID: 24012687
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Risk factors and outcomes associated with severe clostridium difficile infection in children.
    Kim J; Shaklee JF; Smathers S; Prasad P; Asti L; Zoltanski J; Dul M; Nerandzic M; Coffin SE; Toltzis P; Zaoutis T
    Pediatr Infect Dis J; 2012 Feb; 31(2):134-8. PubMed ID: 22031485
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in the Elderly: Long-Term Outcomes and Microbiota Changes.
    Girotra M; Garg S; Anand R; Song Y; Dutta SK
    Dig Dis Sci; 2016 Oct; 61(10):3007-3015. PubMed ID: 27447476
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clostridium difficile infection (CDI) severity and outcome among patients infected with the NAP1/BI/027 strain in a non-epidemic setting.
    Scardina T; Labuszewski L; Pacheco SM; Adams W; Schreckenberger P; Johnson S
    Infect Control Hosp Epidemiol; 2015 Mar; 36(3):280-6. PubMed ID: 25695169
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics.
    Garey KW; Dao-Tran TK; Jiang ZD; Price MP; Gentry LO; Dupont HL
    J Hosp Infect; 2008 Oct; 70(2):142-7. PubMed ID: 18723249
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Recurrence of Clostridium difficile infection among veterans with spinal cord injury and disorder.
    Ramanathan S; Johnson S; Burns SP; Kralovic SM; Goldstein B; Smith B; Gerding DN; Evans CT
    Am J Infect Control; 2014 Feb; 42(2):168-73. PubMed ID: 24485372
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Proton pump inhibitors and risk for recurrent Clostridium difficile infection.
    Linsky A; Gupta K; Lawler EV; Fonda JR; Hermos JA
    Arch Intern Med; 2010 May; 170(9):772-8. PubMed ID: 20458084
    [TBL] [Abstract][Full Text] [Related]  

  • 78. High morbidity and mortality of Clostridium difficile infection and its associations with ribotype 002 in Hong Kong.
    Wong SH; Ip M; Hawkey PM; Lo N; Hardy K; Manzoor S; Hui WW; Choi KW; Wong RY; Yung IM; Cheung CS; Lam KL; Kwong T; Wu WK; Ng SC; Wu JC; Sung JJ; Lee N
    J Infect; 2016 Aug; 73(2):115-22. PubMed ID: 27246801
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hospital cost of Clostridium difficile infection including the contribution of recurrences in French acute-care hospitals.
    Le Monnier A; Duburcq A; Zahar JR; Corvec S; Guillard T; Cattoir V; Woerther PL; Fihman V; Lalande V; Jacquier H; Mizrahi A; Farfour E; Morand P; Marcadé G; Coulomb S; Torreton E; Fagnani F; Barbut F;
    J Hosp Infect; 2015 Oct; 91(2):117-22. PubMed ID: 26253518
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Asymptomatic Clostridium difficile carriage rate post-fecal microbiota transplant is low: a prospective clinical and stool assessment.
    Allegretti JR; Allegretti AS; Phelps E; Xu H; Kassam Z; Fischer M
    Clin Microbiol Infect; 2018 Jul; 24(7):780.e1-780.e3. PubMed ID: 29104169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.